Skip to content
Recall Observatory FDA recall evidence

Drug product

PF-0.125% Bupivacaine HCl Injection, USP, 625 mg/500 mL (1.25 mg/mL), 500 mL bag, packaged in 10 x 1 IV Bag per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th Street Extension, West Columbia, SC 29172; NDC 69374-970-05

D-1346-2022

August 10, 2022

Class II

Product summary

Firm
Nephron Sterile Compounding Center LLC
Event
Event 90718
Status
Terminated
Classification
Class II
Quantity
2030 bags
Official record key
drug-enforcement:D-1346-2022

Official wording

Reason: CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Code information: Lots: BH2003A, Exp. 8/19/2022; BH2011A, Exp. 11/9/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations